Genenta Science S.p.A. (SAEN) stock
SAENNasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)
Close on Nov 18, 2026Market cap $13.64MP/E –Yield –
Genenta Science S.p.A. operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -€6.87M. The highest annual figure on record is -€2.49M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€6.87M | – |
| FY2024 | Dec 31, 2024 | -€6.24M | – |
| FY2023 | Dec 31, 2023 | -€11.21M | – |
| FY2022 | Dec 31, 2022 | -€7.42M | – |
| FY2021 | Dec 31, 2021 | -€6.96M | – |
| FY2020 | Dec 31, 2020 | -€6.04M | – |
| FY2019 | Dec 31, 2019 | -€2.49M | – |
See a number that looks wrong?